165 related articles for article (PubMed ID: 12692689)
1. Positron emission tomography in the management of lymphomas: a summary.
O'Doherty MJ; Hoskin PJ
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S128-30. PubMed ID: 12692689
[No Abstract] [Full Text] [Related]
2. Value of positron emission tomography in diagnosing subcutaneous panniculitis-like T-cell lymphoma.
Bennani-Baiti B; Yadav S; Flynt L; Bennani-Baiti N
J Clin Oncol; 2015 Apr; 33(10):1216-7. PubMed ID: 25691676
[No Abstract] [Full Text] [Related]
3. FDG PET in the management of lymphoma: a clinical perspective.
Hoskin PJ
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):449-51. PubMed ID: 11914880
[No Abstract] [Full Text] [Related]
4. Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC
J Clin Oncol; 2015 Apr; 33(10):1217. PubMed ID: 25691675
[No Abstract] [Full Text] [Related]
5. Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients.
Spaepen K; Stroobants S; Verhoef G; Mortelmans L
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S97-105. PubMed ID: 12709831
[TBL] [Abstract][Full Text] [Related]
6. Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care.
Kaplan LD
Am J Med; 2002 Mar; 112(4):320-1. PubMed ID: 11893374
[No Abstract] [Full Text] [Related]
7. The role of PET imaging in lymphoma.
Burton C; Ell P; Linch D
Br J Haematol; 2004 Sep; 126(6):772-84. PubMed ID: 15352980
[TBL] [Abstract][Full Text] [Related]
8. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
Specht L
Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography in the management of lymphomas.
O'Doherty MJ; Macdonald EA; Barrington SF; Mikhaeel NG; Schey S
Clin Oncol (R Coll Radiol); 2002 Oct; 14(5):415-26. PubMed ID: 12555882
[TBL] [Abstract][Full Text] [Related]
10. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S88-95. PubMed ID: 12739340
[No Abstract] [Full Text] [Related]
11. [Value of positron emission tomography in treatment of lymphoma patients].
Kuwert T
Strahlenther Onkol; 2001 Mar; 177(3):160-1. PubMed ID: 11285774
[No Abstract] [Full Text] [Related]
12. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
Cheson BD
Radiol Clin North Am; 2008 Mar; 46(2):213-23, vii. PubMed ID: 18619377
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?
Juweid ME
J Nucl Med; 2008 Jan; 49(1):9-12. PubMed ID: 18077522
[No Abstract] [Full Text] [Related]
14. The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment.
Bar-Shalom R; Mor M; Yefremov N; Goldsmith SJ
Semin Nucl Med; 2001 Jul; 31(3):177-90. PubMed ID: 11430525
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.
Spaepen K; Mortelmans L
Q J Nucl Med; 2001 Sep; 45(3):269-73. PubMed ID: 11788819
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients].
Cremerius U; Fabry U; Kröll U; Zimny M; Neuerburg J; Osieka R; Büll U
Nuklearmedizin; 1999; 38(1):24-30. PubMed ID: 9987778
[TBL] [Abstract][Full Text] [Related]
17. FDG positron emission tomography in lymphoma.
Tecnologica MAP Suppl; 2000 Jan; ():9-10. PubMed ID: 10848116
[No Abstract] [Full Text] [Related]
18. Prognostic value of FDG-PET in malignant lymphoma.
Becherer A; Jaeger U; Szabo M; Kletter K
Q J Nucl Med; 2003 Mar; 47(1):14-21. PubMed ID: 12714950
[TBL] [Abstract][Full Text] [Related]
19. PET imaging in lymphoma.
Hutchings M
Expert Rev Hematol; 2009 Jun; 2(3):261-76. PubMed ID: 21082968
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Lymphoma Therapy Using (18)F-FDG PET.
Lowe VJ; Wiseman GA
J Nucl Med; 2002 Aug; 43(8):1028-30. PubMed ID: 12163627
[No Abstract] [Full Text] [Related]
[Next] [New Search]